Augmedix Insiders

AUGXDelisted Stock  USD 2.35  0.00  0.00%   
Augmedix employs about 1.4 K people. The company is managed by 10 executives with a total tenure of roughly 3337 years, averaging almost 333.0 years of service per executive, having 143.0 employees per reported executive. Break down of Augmedix's management performance can provide insight into the company performance.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Augmedix Management Team Effectiveness

The company has return on total asset (ROA) of (0.3061) % which means that it has lost $0.3061 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2978) %, meaning that it created substantial loss on money invested by shareholders. Augmedix's management efficiency ratios could be used to measure how well Augmedix manages its routine affairs as well as how well it operates its assets and liabilities.

Augmedix Workforce Comparison

Augmedix is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,684. Augmedix totals roughly 1,430 in number of employees claiming about 85% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.64.

Augmedix Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Augmedix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Augmedix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Augmedix insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Augmedix Notable Stakeholders

An Augmedix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Augmedix often face trade-offs trying to please all of them. Augmedix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Augmedix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Emmanuel KrakarisCEO and PresidentProfile
Saurav ChatterjeeChief OfficerProfile
Todd HolvickHead ComplianceProfile
Jonathan HawkinsChief OfficerProfile
Tomer LevySenior EngineeringProfile
Lia WallickHead PeopleProfile
Davin MDChief OfficerProfile
Ian ShakilChief FounderProfile
Paul GinocchioChief OfficerProfile
Sandra BreberChief OfficerProfile

About Augmedix Management Performance

The success or failure of an entity such as Augmedix often depends on how effective the management is. Augmedix management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Augmedix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Augmedix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. The company was founded in 2013 and is headquartered in San Francisco, California. Augmedix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 706 people.
Please note, the imprecision that can be found in Augmedix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Augmedix. Check Augmedix's Beneish M Score to see the likelihood of Augmedix's management manipulating its earnings.

Augmedix Workforce Analysis

Traditionally, organizations such as Augmedix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Augmedix within its industry.

Augmedix Manpower Efficiency

Return on Augmedix Manpower

Revenue Per Employee31.4K
Revenue Per Executive4.5M
Net Loss Per Employee13.4K
Net Loss Per Executive1.9M
Working Capital Per Employee23.2K
Working Capital Per Executive3.3M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Augmedix Stock

If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data